MIPACT Study FAQ
Questions about MIPACT?
Contact 833-249-9563 or MIPACTstudy@med.umich.edu.
- What is the Michigan Predictive Activity and Clinical Trajectories (MIPACT) Study?
- Why should I participate?
- Who can take part?
- How long will the study last?
- What will I need to do if I join the study?
- How do I join the study?
- Do I need to own an Apple Watch to participate in the study?
- Is this going to cost me anything?
- What data will be collected?
- What happens to my data?
- Who will have access to my data?
- How will my privacy be protected?
- Do I get compensated for my time in the study?
- What is the commercial gain associated with this study?
- Whom can I contact if I have questions about the study?
- How do I withdraw from the study?
- What happens if I change my mind about being in this study?
- What is an Institutional Review Board?
What is the Michigan Predictive Activity and Clinical Trajectories (MIPACT) Study?
The MIPACT Study is a University of Michigan research study that aims to understand the relationship between biosensors, health information, and health outcomes. Researchers will collect several types of data from participants including:
- Electronic health records (EHR)
- Participant survey data
- Genetic information
- Blood pressure measurements
- Apple Watch activity and clinical data
With appropriate permissions (such as legal, regulatory, and ethical board), your information may also be shared with other researchers at the University of Michigan, around the world, and with other companies.
This study will not provide any treatment. It will collect information for research purposes. The University of Michigan and Apple are working together to complete this study. The study is sponsored, in part, by Apple Inc.
Why should I participate?
You could help us better understand how Apple Watch technology, genetics, survey data, and electronic health information can help us learn about health, wellness, and the progressions of chronic diseases. You will play an important role in helping researchers understand health outcomes for potentially millions of Americans.
- Must be 18 years or older and resides in the United States
- Must have an iPhone 6S or later with latest version of iOS
- Must understand English
- Must have internet access throughout the study period
- Must be able to use a consumer-friendly home blood pressure cuff
- Must meet additional demographic and clinical requirements
The study team will screen for additional criteria during the enrollment process.
What will I need to do if I join the study?
You will be asked to download three apps to your iPhone, and donate a blood sample (about 2 tablespoons). You will be asked to take your blood pressure twice a day for at least 15 days and wear an Apple Watch daily. The study will provide you with the Apple Watch and a wireless blood pressure cuff.
During the second phase of the study (see How long will the study last?) you will be asked to complete the same tasks, but only monthly, as opposed to daily. Both phases of the study will include health questionnaires and surveys.
How do I join the study?
In order to join the study, interested persons who meet the initial eligibility criteria (see Who can participate?) should call (833) 249-9563 Monday-Friday, 8am-5pm, and Saturday 9am-3pm, to schedule an appointment. Appointments usually to last between one hour (60 minutes) and one and a half hours (90 minutes).
Is this going to cost me anything?
No, the study will not cost you anything directly. There may be indirect costs, as you will transmit the data collected to the study team and Apple using your iPhone’s data plan.
- A blood sample, lab test results, and certain genetic data
- Personal health information, such as demographic information, medical records, and health history
- Device and application data, such as number of steps taken, distance walked, heart rate, blood pressure, survey data, and other biosensor (accelerometer, gyroscope, photoplethysmography) data.
What happens to my data?
Your contact information and other device-related information that directly identifies you will be separated from your other study data and replaced with a random code (coded study data) before it is used for research purposes. As part of the study, Apple will only access coded study data and will not have access to your contact information, device identifiers, biospecimens, and certain electronic health record data (doctor’s notes, images, videos, pharmacy information). Your coded study data will not be linked to other data that Apple may have from your use of other Apple devices and services.
Who will have access to my data?
With appropriate permissions, your data could be shared with approved researchers inside and outside the University of Michigan, including those in other countries and those working with companies, and with Apple.
How will my privacy be protected?
Whenever possible, we will store donated samples and your health information with a code instead of personal information (such as name, date of birth, or medical record number). The more information about you that is combined together, however, the more likely it is you could be identified.
We will protect all the information used by this project so that it can only be accessed by authorized people. The study team will do its best to ensure that the study data is kept private and secure. Your study data will be stored and transmitted using secure systems. However, total confidentiality cannot be 100% guaranteed.
There is always a risk that you could be identified by your blood sample and health information. It is possible that there could be unauthorized access to or a breach of the systems where your data is stored.
No published scientific reports or presentations will identify you directly.
What is the commercial gain associated with this study?
This study has both research and product development purposes. The sponsor has no plans to offer you financial compensation or share any profits from the commercialization of any products, processes, or services developed from your study data. You will not lose any legal rights to which you are entitled by agreeing to participate in this study.
Whom can I contact if I have questions about the study?
The MIPACT study team can be reached at (833) 249-9563 or firstname.lastname@example.org during business hours (M-F, 8am-5pm).
What happens if I change my mind about being in this study?
After you decide to participate, you can withdraw your participation at any time. To stop participating in the study, please call (833) 249-9563. After you withdraw, no additional data will be collected about you for study purposes. Data collected prior to your withdrawal may continue to be used for research purposes.
The study team or sponsor can stop your participation at any time without your consent for the following reasons:
- If you fail to follow directions for participating in the study
- If it is discovered that you do not meet the study requirements (for example, owning an iPhone 6S or later; currently living in the US; willingness to keep contact information updated and be contacted) or if there is a clinical reason for you to stop participating in the study);
- If the study is terminated
What is an Institutional Review Board?
An institutional review board (IRB) is an independent committee established to help protect the rights of research participants. If you have any questions about your rights as a research participant, and/or concerns or complaints regarding this research study, you should contact the Institutional Review Board at:
2800 Plymouth Rd, Bldg. 520, Room 3214
Ann Arbor, MI 48109-2800
Reference this study (MIPACT), with HUM#00148297, in your communication. The IRB will not be able to answer any study- or app-related questions; for all questions about the research study, including technical support, please call (833) 249-9563.
For more information about the IRB, please visit this link.
Study Team Contact Hours
Disclaimer: These FAQ are meant to serve as guidelines only and may be updated if needed. Study participants with questions should call (833) 249-9563 or email email@example.com.